Walleye Trading’s Definium Therapeutics DFTX Stock Holding History

Walleye Trading’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$868K	Buy	18,450 +13,036	+241%	+$322K	﹤0.01%	2376
2026 Q1	$102K	Buy	5,414 +1,158	+27%	+$19.7K	﹤0.01%	3449
2025 Q4	$57K	Buy	4,256 +3,694	+657%	+$45.7K	﹤0.01%	3916
2025 Q3	$6.63K	Buy	+562	New	+$5.24K	﹤0.01%	4227
2025 Q2	–	Sell	-2,910	Closed	-$17K	–	4539
2025 Q1	$17K	Buy	+2,910	New	+$20.8K	﹤0.01%	3811

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Walleye Trading's DFTX Position: Q2 2026 in Review

Walleye Trading increased its Definium Therapeutics (DFTX) stake by 241% in Q2 2026, buying an estimated $322K and bringing the position to 18,450 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Walleye Trading first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Walleye Trading held 18,450 shares of Definium Therapeutics worth $868K as of Q2 2026.
Walleye Trading bought 13,036 Definium Therapeutics shares in Q2 2026, an estimated $322K.
Definium Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2376 holding.
Walleye Trading first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.